Keywords: thrombogenics, initiates, ph, iib, trial, leuven, belgium-based

ThromboGenics initiates Ph IIb US trial

Article | 15 January 2007

Leuven, Belgium-based biotechnology firm ThromboGenics NV has initiated a Phase IIb US clinical trial of microplasmin in vitrectomy. The company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing